Nanjing Tianyinshan Hospital, a private Class 3A oncology specialist hospital invested in by Hengrui Medicine (SHA: 600276), commenced operations on December 22. The hospital is headed by Professor Qin Shukui, a prominent figure in the field of oncology.
Situated in the Nanjing Jiangning High Tech Zone, the hospital spans a total construction area of 360,000 square meters and features 1,000 beds. Construction on the facility began in 2020, and it obtained its medical institution qualification from the Jiangsu Provincial People’s Government at the start of 2022.- Flcube.com
